Merck’s HPV Vaccine Cleared For Use by FDA Last Week

It’s the beginning of a new cycle of change in cervical cancer screening and treatment

IT’S BEEN A RACE between two pharma giants to get an HPV (Human papillomavirus) vaccine into the market. Last Thursday, Merck & Co., Inc. jumped ahead of GlaxoSmithKline. That was the day that the Food and Drug Administration (FDA) cleared Merck’s Gardisil® for use in the United States. GlaxoSmithKline indicates that it expects to submit …

Merck’s HPV Vaccine Cleared For Use by FDA Last Week Read More »

To access this post, you must purchase The Dark Report.

The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com

Merck’s HPV Vaccine Cleared For Use by FDA Last Week

It’s the beginning of a new cycle of change in cervical cancer screening and treatment

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!

You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

You have read 0 of 1 of your complimentary articles this month